TLR7 and systemic lupus erythematosus: Moreover, in vivo studies showed that treatment with PKM2 inhibitors significantly reduced the glomerular deposition of IgG and IgM in lupus mice induced by imiquimod (a TLR7 agonist) thus protecting the mice against lupus progression (Zhang et al. 2021).